Voloridge Investment Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,343,260
Closed -$90.1M 1230
2024
Q3
$90.1M Buy
+1,343,260
New +$110M 0.33% 64
2024
Q2
Sell
-56,027
Closed -$7.77M 1240
2024
Q1
$7.77M Buy
+56,027
New +$7.04M 0.03% 546
2023
Q3
Sell
-9,732
Closed -$1.25M 1440
2023
Q2
$1.25M Sell
9,732
-71,922
-88% -$8.7M 0.01% 1077
2023
Q1
$9.49M Buy
+81,654
New +$9.14M 0.05% 466
2022
Q1
Sell
-509,176
Closed -$68.4M 1443
2021
Q4
$68.4M Buy
509,176
+69,760
+16% +$10M 0.37% 38
2021
Q3
$60.1M Buy
439,416
+327,800
+294% +$41.3M 0.39% 37
2021
Q2
$11.9M Buy
111,616
+106,540
+2,099% +$10.2M 0.08% 347
2021
Q1
$456K Sell
5,076
-115,064
-96% -$10.8M ﹤0.01% 1199
2020
Q4
$11.1M Buy
+120,140
New +$10.7M 0.09% 252
2020
Q2
Sell
-68,008
Closed -$4.58M 1313
2020
Q1
$4.58M Sell
68,008
-98,848
-59% -$6.15M 0.13% 176
2019
Q4
$9.13M Buy
+166,856
New +$7.91M 0.18% 147
2019
Q3
Sell
-254,248
Closed -$9.52M 1097
2019
Q2
$9.52M Buy
254,248
+178,804
+237% +$5.62M 0.26% 80
2019
Q1
$2.25M Buy
+75,444
New +$2.65M 0.07% 271
2015
Q4
Sell
-102,500
Closed -$2.2M 216
2015
Q3
$2.2M Buy
+102,500
New +$2.29M 0.1% 171

Other funds holding DXCM

Voloridge Investment Management's DXCM Position: Q4 2024 in Review

Voloridge Investment Management sold out of DexCom (DXCM) in Q4 2024, closing a stake of 1,343,260 shares — an estimated $90.1M sold.

Voloridge Investment Management first reported a position in DXCM in Q3 2015 and held it in 14 quarters. The position peaked at $90.1M in Q3 2024. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • Voloridge Investment Management reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
  • Voloridge Investment Management sold 1,343,260 DexCom shares in Q4 2024, an estimated $90.1M.
  • Voloridge Investment Management first reported a position in DexCom in Q3 2015 and held it in 14 quarters.
  • Voloridge Investment Management's DexCom position peaked at $90.1M in Q3 2024.
  • 950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Voloridge Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.